SC 13D
SCHEDULE 13D DECEMBER 13, 2011
- Company
- BioRestorative Therapies, Inc.
- Filed
- February 15, 2013
- Accession Number
- 0001021771-13-000010
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →